Top Markets
#1 Gama Token Gama Token +9.13%
#2 Casper Network Casper Network +6.29%
#3 Berachain Berachain +4.11%
#4 Perle Perle +4.10%
#5 Cross Cross +3.98%
#6 Holoworld Holoworld +3.25%
#7 Venom Venom +3.12%
#8 Tutorial Tutorial +3.07%
#9 The Innovation Game The Innovation Game +3.01%
#10 Velvet Velvet +2.84%
Coin of the day
Gama Token Gama Token
Settings
Language
ENGLISH
Currency
USD
Theme
LFTD Partners Inc. LFTD Partners Inc.

LFTD Partners Inc.

LIFD
Rank in Stocks #36250
LFTD Partners Inc., operating through its subsidiary Lifted Made, specializes... LFTD Partners Inc., operating through its subsidiary Lifted Made, specializes in the production and distribution of two distinct product lines. The first consists of psychedelic products, marketed under their Silly Shruum brand. The second encompasses hemp-derived cannabinoid products, which they sell under the Urb Finest Flowers label. Established in 1986, the company was previously known as Acquired Sales Corp. before officially rebranding to LFTD Partners Inc. in September 2021. Its corporate headquarters are located in Jacksonville, Florida.
Share Price
$0.194
Last synced: 2026-08-14
Market Cap
$2.88M
Change (1 day)
-3.00%
Change (1 year)
-32.56%
Country
US
Trade LFTD Partners Inc. (LIFD)

Category

Healthcare
P/E ratio for LFTD Partners Inc. (LIFD)
P/E ratio as of 2026 TTM: 0
According to LFTD Partners Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for LFTD Partners Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.